Varaico: Literature-Extracted Genetic Variants

Gene:ABCA4
Variant:p.V256_L257Splc
Back to variants list

ABCA4

NM_000350.3:p.V256_L257Splc

Associated Papers

Genetic Correlates of Phenotypic Variability in c.5882G>A p.(Gly1961Glu)-Associated Stargardt Disease.

Pas JAAH et al.

Investigative Ophthalmology & Visual Science, 2026

Characterization of the Subclinical Perilesional Zone in the Macula of Early-Stage ABCA4 Disease.

Zee A et al.

Translational Vision Science & Technology, 2025

Stargardt's Disease: Molecular Pathogenesis and Current Therapeutic Landscape.

Dayma K et al.

International Journal of Molecular Sciences, 2025

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.

Cheerie D et al.

American Journal of Human Genetics, 2025

40139194 (PubMed )
Supplement: mmc2.pdf

ABCA4 Deep Intronic Variants Contributed to Nearly Half of Unsolved Stargardt Cases With a Milder Phenotype.

Wang Y et al.

Investigative Ophthalmology & Visual Science, 2025

39883546 (PubMed )
Supplement: iovs-66-1-65_s009.xlsx › Sheet1

Lipopeptide-mediated Cas9 RNP delivery: A promising broad therapeutic strategy for safely removing deep-intronic variants in ABCA4.

Vázquez-Domínguez I et al.

Molecular Therapy. Nucleic Acids, 2024

39494150 (PubMed )
Supplement: mmc4.pdf

Screening of Inherited Retinal Disease Patients in a Low-Resource Setting Using an Augmented Next-Generation Sequencing Panel.

Midgley N et al.

Molecular Genetics & Genomic Medicine, 2024

18-Years of single-centre DNA testing in over 7000 index cases with inherited retinal dystrophies and optic neuropathies.

Kiel C et al.

Scientific Reports, 2024

39462066 (PubMed )
Supplement: 41598_2024_77014_MOESM2_ESM.xlsx › unsolved_patients

Functional Characterization of ABCA4 Missense Variants Aids Variant Interpretation and Phenotype Prediction in Patients With ABCA4-Retinal Dystrophies.

Aslaksen S et al.

Investigative Ophthalmology & Visual Science, 2024

Genetic Characterization of 191 Probands with Inherited Retinal Dystrophy by Targeted NGS Analysis.

Mihalich A et al.

Genes, 2024

Preclinical Development of Antisense Oligonucleotides to Rescue Aberrant Splicing Caused by an Ultrarare ABCA4 Variant in a Child with Early-Onset Stargardt Disease.

Suárez-Herrera N et al.

Cells, 2024

Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes.

Hitti-Malin RJ et al.

Biomolecules, 2024

Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4.

Suárez-Herrera N et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy, 2024

Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.

Li CHZ et al.

Ophthalmology, 2024

Targeted sequencing and in vitro splice assays shed light on ABCA4-associated retinopathies missing heritability.

Corradi Z et al.

Hgg Advances, 2023

Natural History of Stargardt Disease: The Longest Follow-Up Cohort Study.

Sajovic J et al.

Genes, 2023

A framework for individualized splice-switching oligonucleotide therapy.

Kim J et al.

Nature, 2023

37438524 (PubMed )
Supplement: 41586_2023_6277_MOESM4_ESM.xlsx › S_Table_15

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis.

Panneman DM et al.

Frontiers in Cell and Developmental Biology, 2023

36819107 (PubMed )
Supplement: Table2.XLSX › DIVs

Compendium of Clinical Variant Classification for 2,246 Unique ABCA4 Variants to Clarify Variant Pathogenicity in Stargardt Disease Using a Modified ACMG/AMP Framework.

Cornelis SS et al.

Human Mutation, 2023

Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease

Tomkiewicz TZ et al.

Cells, 2022

Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases.

Hitti-Malin RJ et al.

Human Mutation, 2022

36259723 (PubMed )
Supplement: HUMU-43-2234-s007.xlsx › DIVs

A genotype-phenotype correlation matrix for ABCA4 disease based on long-term prognostic outcomes.

Lee W et al.

Jci Insight, 2022

Corrigendum: Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan NP et al.

Frontiers in Genetics, 2022

35754842 (PubMed )
Supplement: DataSheet1.xlsx › Table_S1

An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story.

Al-Khuzaei S et al.

Genes, 2021

Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes.

Moles-Fernández A et al.

Cancers, 2021

34283047 (PubMed )
Supplement: cancers-13-03341-s001.zip › 1_Supplementary_table_S1.xlsx › Suppl_tab_1

Benchmarking deep learning splice prediction tools using functional splice assays.

Riepe TV et al.

Human Mutation, 2021

33942434 (PubMed )
Supplement: HUMU-42-799-s001.xlsx › ABCA4_DI

Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease.

Lee W et al.

Human Molecular Genetics, 2021

Clinical and Genetic Spectrum of Stargardt Disease in Argentinean Patients.

Mena MD et al.

Frontiers in Genetics, 2021

33841504 (PubMed )
Supplement: Data_Sheet_2.xlsx › Supplementary_Table_2

Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan NP et al.

Frontiers in Genetics, 2021

1–50 of 65 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."